Table of Contents
ISRN Molecular Imaging
Volume 2013, Article ID 710305, 7 pages
http://dx.doi.org/10.1155/2013/710305
Clinical Study

18F-fluoro-L-thymidine Positron Emission Tomography for Mucosal Head and Neck Squamous Cell Carcinoma Treated with Definitive Chemoradiation: A Pilot Study of Nodal Assessment and Tracer Safety

1Cancer Care Services, Royal Brisbane and Women’s Hospital, Butterfield Street, Herston, QLD 4029, Australia
2Department of Nuclear Medicine, Royal Brisbane and Women’s Hospital, Butterfield Street, Herston, QLD 4029, Australia
3Queensland Institute of Medical Research, 300 Herston Road, Herston, QLD 4006, Australia
4Diagnostic Imaging, Royal Brisbane and Women’s Hospital, Butterfield Street, Herston, QLD 4029, Australia
5Oceania Oncology Sunshine Coast, P.O. Box 8040, Maroochydore DC, QLD 4558, Australia
6Department of Radiation Oncology, Calvary Mater Newcastle, Locked Bag 7, Hunter Region Mail Centre, NSW 2310, Australia

Received 9 January 2013; Accepted 21 February 2013

Academic Editors: H. Hendrikse, P. Lass, I. Matsunari, and J. Mertens

Copyright © 2013 Charles Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Martínez-Villaseñor and A. Vidaurré-Domínguez, “Scintillography in the diagnosis of malignant neoplasms,” Gaceta Medica de Mexico, vol. 107, no. 2, pp. 165–174, 1974. View at Google Scholar
  2. N. Oriuchi, T. Higuchi, T. Ishikita et al., “Present role and future prospects of positron emission tomography in clinical oncology,” Cancer Science, vol. 97, no. 12, pp. 1291–1297, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. L. L. Myers, M. K. Wax, H. Nabi, G. T. Simpson, and D. Lamonica, “Positron emission tomography in the evaluation of the N0 neck,” Laryngoscope, vol. 108, no. 2, pp. 232–236, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Pauleit, A. Zimmermann, G. Stoffels et al., “18F-FET PET compared with18F-FDG PET and CT in patients with head and neck cancer,” Journal of Nuclear Medicine, vol. 47, no. 2, pp. 256–261, 2006. View at Google Scholar · View at Scopus
  5. J. W. Fletcher, B. Djulbegovic, H. P. Soares et al., “Recommendations on the use of 18F-FDG PET in oncology,” Journal of Nuclear Medicine, vol. 49, no. 3, pp. 480–508, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Mier, U. Haberkorn, and M. Eisenhut, “[18F]FLT; portrait of a proliferation marker,” European Journal of Nuclear Medicine, vol. 29, no. 2, pp. 165–169, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Hoshikawa, Y. Nishiyama, T. Kishino, Y. Yamamoto, R. Haba, and N. Mori, “Comparison of FLT-PET and FDG-PET for visualization of head and neck squamous cell cancers,” Molecular Imaging and Biology, vol. 13, no. 1, pp. 172–177, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. K. Buck, M. Hetzel, H. Schirrmeister et al., “Clinical relevance of imaging proliferative activity in lung nodules,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 32, no. 5, pp. 525–533, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. C. S. Yap, J. Czernin, M. C. Fishbein et al., “Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography,” Chest, vol. 129, no. 2, pp. 393–401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. D. C. P. Cobben, P. H. Elsinga, H. J. Hoekstra et al., “Is 18F-3′ -fluoro-3′ -deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?” Journal of Nuclear Medicine, vol. 45, no. 10, pp. 1677–1682, 2004. View at Google Scholar · View at Scopus
  11. B. Kasper, G. Egerer, M. Gronkowski et al., “Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography comparing FDG- and FLT-PET,” Leukemia and Lymphoma, vol. 48, no. 4, pp. 746–753, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Kenny, R. C. Coombes, D. M. Vigushin, A. Al-Nahhas, S. Shousha, and E. O. Aboagye, “Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[ 18F]fluorothymidine positron emission tomography,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, no. 9, pp. 1339–1347, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. B. S. Pio, C. K. Park, R. Pietras et al., “Usefulness of 3′ -[F-18]fluoro-3′ -deoxythymidine with positron emission tomography in predicting breast cancer response to therapy,” Molecular Imaging and Biology, vol. 8, no. 1, pp. 36–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. D. C. P. Cobben, B. F. A. M. Van Der Laan, B. Maas et al., “18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET,” Journal of Nuclear Medicine, vol. 45, no. 2, pp. 226–231, 2004. View at Google Scholar · View at Scopus
  15. E. G. C. Troost, W. V. Vogel, M. A. W. Merkx et al., “18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients,” Journal of Nuclear Medicine, vol. 48, no. 5, pp. 726–735, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Flexner, C. Van der Horst, M. A. Jacobson et al., “Relationship between plasma concentrations of 3′ -deoxy-3′ -fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials,” Journal of Infectious Diseases, vol. 170, no. 6, pp. 1394–1403, 1994. View at Google Scholar · View at Scopus
  17. S. B. Edge and C. C. Compton, “The american joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM,” Annals of Surgical Oncology, vol. 17, no. 6, pp. 1471–1474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. E. Juweid, D. Thomas, Y. Menda et al., “PET/CT with 18F-FLT is unlikely to cause significant hepatorenal or hematologic toxicity,” Journal of Nuclear Medicine, vol. 51, no. 5, pp. 824–825, 2010. View at Google Scholar · View at Scopus
  19. E. Goshen, T. Davidson, R. Yahalom, Y. P. Talmi, and S. T. Zwas, “PET/CT in the evaluation of patients with squamous cell cancer of the head and neck,” International Journal of Oral and Maxillofacial Surgery, vol. 35, no. 4, pp. 332–336, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. H. S. Jeong, C. H. Baek, Y. I. Son et al., “Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma,” Head and Neck, vol. 29, no. 3, pp. 203–210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. M. R. Kim, J. L. Roh, J. S. Kim et al., “Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx,” European Journal of Surgical Oncology, vol. 33, no. 5, pp. 633–638, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Minovi, A. Hertel, A. Ural, E. Hofmann, W. Draf, and U. Bockmuehl, “Is PET superior to MRI in the pretherapeutic evaluation of head and neck squamous cell carcinoma?” Journal of Ear, Nose, and Throat, vol. 17, no. 6, pp. 324–328, 2007. View at Google Scholar · View at Scopus
  23. D. Y. Yoon, H. S. Hwang, S. K. Chang et al., “CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck,” European Radiology, vol. 19, no. 3, pp. 634–642, 2009. View at Publisher · View at Google Scholar · View at Scopus